Baker Bros. Advisors LP Harpoon Therapeutics, Inc. Transaction History

Baker Bros. Advisors LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$11.11 - $24.72 $2.27 Million - $5.05 Million	-204,467 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$10.74 - $16.32 $105,445 - $160,229	-9,818 Reduced 4.58%	204,467 $2.37 Million
Q1 2019 May 15, 2019	BUY	$9.47 - $17.01 $2.03 Million - $3.64 Million	214,285 New	214,285 $2.03 Million

353K

Ticker HARP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,106,800
Description
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Baker Bros. Advisors LP with notifications on news.